Abstract

BackgroundMaternal recto-vaginal colonization with Group B Streptococcus (GBS) and consequent vertical transmission to the newborn predisposes neonates to early-onset invasive GBS disease. This study aimed to determine the acquisition and loss of serotype-specific recto-vaginal GBS colonization from 20–37+ weeks of gestational age.MethodsVaginal and rectal swabs were collected from HIV-uninfected women at 20–25 weeks of gestation age and at 5–6 weekly intervals thereafter. Swabs were cultured for GBS and isolates were serotyped by latex agglutination. Serologically non-typable isolates and pilus islands were characterized by PCR.ResultsThe prevalence of recto-vaginal GBS colonization was 33.0%, 32.7%, 28.7% and 28.4% at 20–25 weeks, 26–30 weeks, 31–35 weeks and 37+ weeks of gestational age, respectively. The most common identified serotypes were Ia (39.2%), III (32.8%) and V (12.4%). Of 507 participants who completed all four study visits, the cumulative overall recto-vaginal acquisition rate of new serotypes during the study was 27.9%, including 11.2%, 8.2% and 4.3% for serotypes Ia, III and V, respectively. Comparing the common colonizing serotypes, serotype III was more likely to be associated with persistent colonization throughout the study (29%) than Ia (18%; p = 0.045) or V (6%; p = 0.002). The median duration of recto-vaginal GBS colonization for serotype III was 6.35 weeks, which was longer than other serotypes. Pilus island proteins were detected in all GBS isolates and their subtype distribution was associated with specific serotypes.ConclusionSouth African pregnant women have a high prevalence of GBS recto-vaginal colonization from 20 weeks of gestational age onwards, including high GBS acquisition rates in the last pregnancy-trimesters. There are differences in specific-serotype colonization patterns during pregnancy.

Highlights

  • Maternal vaginal colonization with Group B Streptococcus (GBS) is the major risk factor for early onset invasive GBS disease (EOD) in newborns [1,2]

  • Studies have identified an association between high maternal serotype-specific anti-capsular polysaccharide (CPS) antibody concentrations with reduced risk of recto-vaginal colonization and reduced risk of newborns developing EOD [4,5]

  • Since GBS CPS-protein conjugate vaccines are serotype-specific, it is important to characterize the serotype distribution of GBS in different regions of the world as well as understand the changes which occur in GBS colonization during pregnancy [6]

Read more

Summary

Introduction

Maternal vaginal colonization with Group B Streptococcus (GBS) is the major risk factor for early onset invasive GBS disease (EOD) in newborns [1,2]. Studies have identified an association between high maternal serotype-specific anti-capsular polysaccharide (CPS) antibody concentrations with reduced risk of recto-vaginal colonization and reduced risk of newborns developing EOD [4,5]. It has been shown that maternal GBS colonization during pregnancy may fluctuate [8,9,10], there are limited longitudinal studies on the rate of serotype-specific GBS acquisition and duration of colonization during pregnancy. Maternal recto-vaginal colonization with Group B Streptococcus (GBS) and consequent vertical transmission to the newborn predisposes neonates to early-onset invasive GBS disease. This study aimed to determine the acquisition and loss of serotype-specific recto-vaginal GBS colonization from 20–37+ weeks of gestational age

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call